-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Arcus Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2019 to Q2 2024.
- Arcus Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 91.1M shares, a 24.5% increase year-over-year.
- Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 74M shares, a 2.78% increase from 2022.
- Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 72M shares, a 2.7% decline from 2021.
- Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 74M shares, a 35% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)